tapebrief

XYL · Q1 2026 Earnings

Cautious

Xylem Inc.

Reported April 28, 2026

30-second summary

Xylem delivered Q1 revenue of $2.13B (+2.7% YoY, flat organic) and adjusted EPS of $1.12 — both above the Q4-issued guide — with adjusted EBITDA margin of 20.6%, near the low end of the 20.5–21% band. Management raised the FY26 revenue guide by $100M at midpoint to $9.2–$9.3B but explicitly held EPS unchanged at $5.35–$5.60 despite buyback accretion, calling it "a prudent approach to guidance in an uncertain macro environment." A $850M 20-year outsourced water contract — Xylem's largest ever — is the bull-case anchor; flat organic growth and a 30% China decline are the offset.

Headline numbers

EPS

Q1 FY2026

$1.12

Revenue

Q1 FY2026

$2.13B

+2.7% YoY

Gross margin

Q1 FY2026

37.8%

Free cash flow

Q1 FY2026

$0.02B

Operating margin

Q1 FY2026

11.5%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$2.13B+2.7%$2.40B-11.3%
EPS$1.12$1.42-21.1%
Gross margin37.8%38.2%-40bps
Operating margin11.5%14.7%-320bps
Free cash flow$0.02B

Guidance

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
EPS (non-GAAP)Q1 FY2026$1.06 to $1.11$1.12+$0.01 above guideBeat
RevenueQ1 FY20261% to 2% reported growth2.7% YoY growth+0.7–1.7 pts above guide rangeBeat
Organic Revenue GrowthQ1 FY2026flatflatin-lineBeat
EBITDA MarginQ1 FY202620.5% to 21%20.6%in-lineBeat

New guidance

MetricPeriodGuideYoY
RevenueQ2 FY2026$2.29–$2.35B-0.4% to +2.2% YoY
Revenue reported growthQ2 FY20262% to 3%
Revenue organic growthQ2 FY2026roughly 1%

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Revenue
FY2026
$9.1–$9.2B$9.2–$9.3B+$0.1B midpoint (from $9.15B to $9.25B)Raised
Revenue reported growth
FY2026
1% to 3%2% to 3%+1 pt on low endRaised

Reaffirmed unchanged this quarter: Revenue organic growth (2% to 4%), Adjusted EBITDA Margin (22.9% to 23.3%), Free Cash Flow Margin (10.2% to 11.0%), EPS (non-GAAP) ($5.35 to $5.60)

Segment KPIs

Q1 FY2026
SegmentQ1 FY2026YoY
Water Infrastructure$0.603B+4.0%
Applied Water$0.448B+3.0%
Measurement and Control Solutions$0.508B+4.0%
Water Solutions and Services$0.566B+1.0%

Other KPIs

Q1 FY2026
SegmentQ1 FY2026
Orders$2.2 billion
Organic Orders Growthflat
Organic Revenue Growthflat
Adjusted EBITDA Margin20.6%
Net Income Margin9.1%
Book-to-Bill Ratio1.05

Management tone

Q2 anchor → Q3 anchor → Q4 anchor → Q1 anchor: 80-20 as proof point → 80-20 as cultural operating model → 80-20 as deliberate growth sacrifice → resilience-as-mantra under macro pressure.

Tone reframed from confident execution to prudent defense. Three quarters ago management was advertising that its February guide had been too low ("meaningfully outperform initial guidance"). Last quarter it pre-announced a 2% self-inflicted top-line headwind as a feature. This quarter the framing flips defensive: "2026 is proving resilient with a solid first quarter financial performance despite a dynamic external environment." The shift from "outperform" to "resilient" in two quarters is a meaningful downshift in posture — particularly when paired with the choice to absorb buyback accretion into the EPS range rather than raise it.

EPS guide held against buyback math is the loudest signal. This quarter management had a tailwind from Q1 buybacks and chose to keep the range exactly where it was: "Despite the benefit from share purchases, we've chosen to keep our EPS range unchanged at $5.35 to $5.60, reflecting a prudent approach to guidance in an uncertain macro environment." A reaffirmation in name is a soft cut in substance — management traded a near-certain EPS raise for a wider safety margin against macro deterioration it isn't yet willing to forecast.

Risk inventory broadened from one variable to five. Through 2025 China was the named risk. This quarter the list expands explicitly: "the Middle East conflict, changes in tariffs, and other inflationary pressures, along with fluctuations in currency and interest rates." When the risks section starts itemizing multiple geopolitical and macro vectors in prepared text, management is preparing investors for the possibility that any one of them moves and explains why guidance didn't progress.

WSS megacontract reframed as visibility anchor, not growth catalyst. The $850M outsourced water contract — Xylem's largest ever — would in a different tone quarter be framed as proof of phase-two growth engine wins. Instead it shows up as long-duration ballast: 10% recognized this year, capital completing next year, service revenue not starting until 2028 and stretching 20 years. Management is leaning on contracted backlog as a confidence anchor precisely because organic momentum is flat and getting flatter into Q2.

Phase two language has gone quiet. Last quarter management declared the phase-two "growth engine" transition active and set the $1B M&A deployment target as forward narrative. This quarter the M&A story still works — the $219M water quality instruments tuck-in is on the books — but the "growth engine" framing has been replaced by margin protection and backlog citation. The phase-two narrative isn't dead, but it's been deferred behind the macro defense.

Recurring themes management leaned on this quarter:

Operational transformation and simplification improving resilienceMargin expansion through productivity and price offsetting inflationStrong backlog and book-to-bill supporting demand narrativeCapital allocation discipline with balanced approach to shareholder returnsChina headwinds and macro uncertainty creating near-term revenue pressureData center and smart metering growth offsetting traditional market softness

Risks management surfaced:

China headwinds and regional softness in Western EuropeMiddle East conflictChanges in tariffs and potential inflationary pressuresCurrency and interest rate fluctuationsProject timing volatility in capital project segments

Q&A highlights

Dean Dre · RBC Capital Markets

Requested details on the outsource contract including customer identity, economics, and pipeline for similar contracts

Management disclosed it's an existing specialty chemical customer providing process water for cooling and boiler feed; contract is $850M (75% service, 25% capital), with 10% realized in current year, capital completion next year, and service revenue starting 2028 spanning 20 years

$850 million contract value75% service, 25% capital split10% of contract value realized in current yearService tail begins 2028

Andy Kaplowitz · Citigroup

Asked about price versus inflation dynamics across portfolio and conviction on margin trajectory, particularly for Applied Water reaching 20%

Management stated portfolio is price-cost positive; teams proactive on pricing and sourcing; Applied Water underperformance attributed to sales mix rather than fundamental issues; confident in return to 20%+ margins through cost actions and normalization of data center projects

Price-cost positive across portfolioFuel surcharges implemented to offset inflationApplied Water margin recovery expected through balance of yearData center project mix expected to normalize with higher margins

Jacob Olson · Mellis Research

Asked about measurement and control cycle positioning for electric versus water refresh cycles, and China market bottom

Management outlined 5-7 year lag: electric utilities completed AMI refresh (post-2008 stimulus), water refresh expected 2030 onwards; China down 30% YoY, attributed to one-third market, one-third competitor actions, one-third deliberate walkaway; believes bottoming out with easier comps ahead

Electric AMI refresh timeline: 2008-2024Water refresh cycle expected 2030 onwards5-7 year lag between electric and water refresh cyclesChina down 30% year-over-year

Mike Halloran · Baird

Asked about capital allocation priorities including buyback intent, M&A pipeline, and rationale for water quality analytics acquisition

Management targeting net debt to EBITDA between 0.5x-1.0x turn; continuing buybacks in April with reassessment end-Q2; $1B M&A deployment target outlined; recent $219M acquisition is highly engineered water quality instruments business with significant revenue synergy potential through customer leverage

$219 million acquisition price for water quality instruments business$1 billion M&A deployment targetTarget net debt/EBITDA: 0.5x to 1.0xContinued buybacks in April with Q2 reassessment

Nathan Jones · Stifel

Asked about MNCS orders supporting growth trajectory given double-digit order growth but orders below revenue levels, and margin expansion drivers for H2

Management indicated long-term normalized order growth target is high single-digit; sequential backlog increase despite lower quarter-orders reflects large project wins with firm commitments; H2 margin expansion driven by volume growth and mix normalization from MCS projects and China walkaway completion

Long-term normalized order growth target: high single-digitBook and chip up 9%Backlog increased sequentiallyLarge project wins have firm commitments for near-term delivery

Answers to last quarter's watch list

Q1 FY26 organic growth flat vs Q4's +4% print — Organic landed flat exactly as guided, reported revenue +2.7% beat the 1–2% guide range. The flat organic print did not signal accelerating deterioration, and management reaffirmed the full-year 2–4% organic band. However, Q2 organic is now guided to "roughly 1%," meaning the walkaway and China headwinds are clearly front-half loaded, requiring acceleration in H2 to hit even the low end of the FY range.
Continue monitoring
Orders/book-to-bill trajectory in Q1 — Orders of $2.2B at book-to-bill 1.05 cleared the 1.0 threshold, but organic order growth was flat — not the +7% organic order growth posted in Q4. The book-to-bill above 1.0 nominally supports the H2 organic ramp, but the flat order-growth print weakens the leading-indicator signal.
Continue monitoring
MCS sustainability after three straight double-digit quarters — MCS decelerated sharply from +13.9% in Q4 to +4% reported (+1% organic) in Q1 — well below the low double-digit floor management had hedged on last quarter. The "project timing more variable" framing from Q4 cashed in immediately. Management points to H2 mix normalization for recovery.
Resolved negatively
M&A deployment pace against the $1B annual target — Management disclosed the $219M water quality instruments acquisition and reaffirmed continued buybacks plus the $1B deployment target with a Q2-end reassessment. Roughly 22% of the annual M&A target deployed in one quarter is on-pace.
Resolved positively
Q1 EBITDA margin of 20.5–21% vs Q4's 23.2% — Delivered 20.6%, within the guide. The implied ~260bps sequential compression landed as guided, meaning the front-loaded walkaway cost was accurately modeled. Management still expects Q2 EBITDA margin of 22–22.5% and FY 22.9–23.3%, implying the H2 ramp is committed.
Resolved positively
China and tariff impact quantification at Q1 — China quantified at -30% YoY with ~1% FY revenue headwind / ~2% H1 headwind, with management explicitly characterizing the decline as one-third market / one-third competitor / one-third deliberate walkaway. Tariff impact described as offset by pricing and fuel surcharges with portfolio price-cost positive, but no fresh dollar quantification of annualized tariff impact. Status: Resolved on China, Continue monitoring on tariff dilution

What to watch into next quarter

Q2 organic growth of "roughly 1%" vs the H2 ramp required to hit FY 2–4% organic — a Q2 organic print below 1% would mathematically force H2 organic to ~5%+ to reach the low end of the FY band, putting the reaffirmed organic guide at risk

EPS guide behavior — whether management raises the $5.35–$5.60 band in Q2 (if macro stabilizes) or leaves it intact again (further softening of the underlying outlook); two consecutive reaffirmations against buyback accretion would mark a clear cut in substance

MCS growth trajectory — Q1's drop from +13.9% to +4% reported needs to either stabilize or recover toward high-single-digit in Q2 to validate the H2 mix-normalization mechanic management cited; another sub-5% print would mean the backlog-conversion story has structurally broken

WSS organic growth ex the $850M contract — Q1 WSS at +1% reported (-2% organic) is the weakest segment print; the megacontract's 10% in-year recognition won't move the segment line meaningfully, so the underlying WSS demand picture is the read

China sequential trajectory — management framed it as bottoming with easier comps ahead; a Q2 print closer to flat sequential (vs further sequential degradation) would confirm the structural floor narrative

M&A deployment pace post-Q2 reassessment — whether management continues the buyback program or pivots harder to M&A given the $1B target

Sources

  1. Xylem Inc. Q1 FY2026 earnings press release (Form 8-K Exhibit 99.1), filed April 28, 2026 — https://www.sec.gov/Archives/edgar/data/1524472/000152447226000065/xyl04282026ex991.htm
  2. Xylem Q1 FY2026 earnings call commentary — prepared remarks and Q&A with Dean Dre (RBC), Andy Kaplowitz (Citi), Jacob Levinson (Melius), Mike Halloran (Baird), Nathan Jones (Stifel)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.